RE:RE:there isalleyesonme wrote: The value lies in the suite of licenses and certifications for cannabinoids as a pharmaceutical ingredient in respective jurisdictions...the time to obtain such licenses once the facility is built could range between 2-4 years...now the cost....GW JAZZ announced expansion to the existing extraction facility in the U.K at 100 million price tag...Once a large pharmaceutical Corp reaches the point of commercialization I would expect they would source API from someone like LABS...if the new drug proves commercially successful they could begin building and then wait years for the licences and certs and probably burn 500m...or they could buy a Corp like labs who's presently only worth 28m and turn key...IMO Labs will be bought, this is the end game, and the C suite knows this which is why their enriching themselves with share based compensation to the tune of 30m shares..
ok at what price as i said in a earlier post .25? max at this point i woud think?